RXO: Q3 Earnings Snapshot

RXO Inc. reported Q3 earnings of $3M, or 2 cents per share, beating expectations of 8 cents per share. Adjusted EPS was 9 cents. Revenue was $1.87B, exceeding forecasts of $1.81B, according to Zacks Investment Research.

Original reporting
Published Oct 29, 2026, 10:35 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 10:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RXO: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$RXOBullishMed
01

Why it matters

The immediate tradable takeaway is the EPS and revenue beat versus surveyed expectations; without guidance, the impact is likely limited to near-term sentiment and revisions.

02

Market read

RXO’s Q3 results beat consensus on both EPS and revenue, which can support short-term positioning and analyst estimate revisions.

03

What to watch

Traders may focus on forward guidance, cash flow, and segment trends, which are absent from this snapshot.

Relevance 7/10Novelty 7/10Timing: reported Q3 earnings snapshot (Thursday)

Background

The article is an AP-generated earnings snapshot for RXO’s third quarter, citing Zacks consensus estimates.

Company-level read

Ticker impact

$RXOBullishMedium confidence
Context

RXO reported Q3 profit of 2 cents per share and adjusted EPS of 9 cents, beating Zacks expectations of 8 cents, with revenue of $1.87B beating $1.81B.

Expected impact

Likely modest upward pressure as the market digests the EPS and revenue beat versus Street estimates.

Evidence & confidence

The piece is a first-report earnings snapshot with explicit beat vs analyst consensus, but it lacks forward guidance, margin detail, or management commentary that would drive a larger repricing.

Market effects

Provides incremental datapoint for transportation services demand and pricing, but no sector-wide read-through is provided.

Limited to company-specific sentiment; no regional macro linkage stated.

No global market or cross-border catalyst mentioned.

Counterpoint

A beat may not sustain if margins, backlog, or guidance are weaker than implied, but those details are not included here.

Key entities

  • RXO Inc.

    Transportation services provider reporting Q3 EPS and revenue that beat analyst estimates.

  • Zacks Investment Research

    Cited as the provider of the Street consensus estimates used for the beat comparison.

Related articles

$RXOMedAI 8/10

RXO stock holds at StoneX as freight rates improve ahead of CHRW deal

StoneX reiterated a Hold rating on RXO, Inc. (NYSE:RXO) after its Q3 adjusted EBITDA of $51M exceeded estimates. RXO's truckload gross profit and margins improved, with spot rates and contract pricing supporting brokerage margins. RXO's stock has surged 120% YTD. C.H. Robinson's $5.8B acquisition of RXO is pending, with mixed analyst reactions on ratings and price targets.

$RXOHigh

RXO’s earnings still coming out, had solid profitable quarter

RXO reported a profitable third quarter with adjusted EBITDA of $51 million, exceeding its forecast. Gross margin was 14.6%, up from Q2 but down from a year ago. CEO Drew Wilkerson highlighted momentum. Brokerage and truckload volumes increased, with a shift toward the spot market. LTL and Last Mile segments also saw growth. RXO's founder supports its acquisition by C.H. Robinson (CHRW).

$CHRWMedAI 8/10

C.H. Robinson leaders tackle RXO friction concerns

C.H. Robinson executives addressed concerns about operational overlap from the $5.8B RXO acquisition, citing manageable overlap and synergies. They emphasized Lean AI strategies for integration. Q3 2023 earnings showed net income of $198.5M and revenue of $5.36B, up 29.5% YoY. North American Surface Transportation and Global Forwarding segments both reported revenue and income growth.

$RXOMedAI 8/10

RXO (NYSE:RXO) exceeds Q3 2026 expectations

RXO reported Q3 2026 revenue of $1.87B, beating estimates by 2.6% and growing 31.7% year-on-year. Adjusted EPS was $0.09, a 20% beat, with adjusted EBITDA at $51M, a 15.1% beat. Operating margin improved to 0.9% from -0.5% last year, while free cash flow margin remained at 0.6%. Sales volumes increased 2% year-on-year.